Company Profile

Ohmx Corporation
Profile last edited on: 2/2/16      CAGE: 45JN3      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2003
First Award
2010
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1801 Maple Avenue Suite 6143
Evanston, IL 60201
   (847) 491-8500
   info@ohmx.com
   www.ohmxbio.com
Location: Single
Congr. District: 09
County: Cook

Public Profile

Ohmx Corporation offers a handheld medical monitoring device that is bioelectronic, low-cost, reagentless and targeted for use by chronic disease patients (e.g. cardiovascular, oncology, renal failure patients and Type II diabetics). The device consists of a disposable biosensor chip and handheld electronic reader that can assess a complete panel of clinical biomarkers and other important disease indicators from a single drop of blood. Ohmx is a bioelectronic detection company developing a monitoring device to be used in all point-of-care (POC) settings, even by the patient as a consumer diagnostic. Once integrated within the existing eHeatlh infrastructure, the device will enable doctors to quickly, cost-effectively, and remotely monitor and manage patients with chronic diseases

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $1,664,117
Project Title: A Bioelectronic Assay for PSA Activity

Key People / Management

  Charles Rowland -- President & CEO

  Dimitra Georganopoulou -- VP of Research and Development

Company News

There are no news available.